Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Functional gene variation in the human norepinephrine transporter: association with attention deficit hyperactivity disorder.

Kim CH, Waldman ID, Blakely RD, Kim KS.

Ann N Y Acad Sci. 2008;1129:256-60. doi: 10.1196/annals.1417.023. Review.

PMID:
18591486
2.

No evidence of an association between norepinephrine transporter gene polymorphisms and attention deficit hyperactivity disorder: a family-based and case-control association study in a Korean sample.

Cho SC, Kim JW, Kim BN, Hwang JW, Park M, Kim SA, Cho DY, Yoo HJ, Chung US, Son JW, Park TW.

Neuropsychobiology. 2008;57(3):131-8. doi: 10.1159/000138916. Epub 2008 Jun 13.

PMID:
18552510
3.

No evidence for association between a functional promoter variant of the Norepinephrine Transporter gene SLC6A2 and ADHD in a family-based sample.

Renner TJ, Nguyen TT, Romanos M, Walitza S, Röser C, Reif A, Schäfer H, Warnke A, Gerlach M, Lesch KP.

Atten Defic Hyperact Disord. 2011 Sep;3(3):285-9. doi: 10.1007/s12402-011-0060-4. Epub 2011 Jul 8.

PMID:
21739117
4.

A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder.

Kim CH, Hahn MK, Joung Y, Anderson SL, Steele AH, Mazei-Robinson MS, Gizer I, Teicher MH, Cohen BM, Robertson D, Waldman ID, Blakely RD, Kim KS.

Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19164-9. Epub 2006 Dec 4.

5.

Norepinephrine transporter polymorphisms in Tourette syndrome with and without attention deficit hyperactivity disorder: no evidence for significant association.

Rippel CA, Kobets AJ, Yoon DY, Williams PN, Shugart YY, Bridges DD, Vandenbergh DJ, Singer HS.

Psychiatr Genet. 2006 Oct;16(5):179-80.

PMID:
16969268
6.

Further evidence of association between two NET single-nucleotide polymorphisms with ADHD.

Kim JW, Biederman J, McGrath CL, Doyle AE, Mick E, Fagerness J, Purcell S, Smoller JW, Sklar P, Faraone SV.

Mol Psychiatry. 2008 Jun;13(6):624-30. Epub 2007 Sep 18.

PMID:
17876324
7.
8.

The norepinephrine transporter in physiology and disease.

Bönisch H, Brüss M.

Handb Exp Pharmacol. 2006;(175):485-524. Review.

PMID:
16722247
9.

A haplotype of the norepinephrine transporter gene (SLC6A2) is associated with visual memory in attention-deficit/hyperactivity disorder.

Shang CY, Chiang HL, Gau SS.

Prog Neuropsychopharmacol Biol Psychiatry. 2015 Apr 3;58:89-96. doi: 10.1016/j.pnpbp.2014.12.010. Epub 2014 Dec 30.

PMID:
25554436
10.

Association studies of -3081(A/T) polymorphism of norepinephrine transporter gene with attention deficit/hyperactivity disorder in Korean population.

Joung Y, Kim CH, Moon J, Jang WS, Yang J, Shin D, Lee S, Kim KS.

Am J Med Genet B Neuropsychiatr Genet. 2010 Mar 5;153B(2):691-694. doi: 10.1002/ajmg.b.31012.

PMID:
19685476
11.

Association between the alpha-2C-adrenergic receptor gene and attention deficit hyperactivity disorder in a Korean sample.

Cho SC, Kim JW, Kim BN, Hwang JW, Shin MS, Park M, Kim SA, Cho DY, Yoo HJ, Chung US, Son JW, Park TW.

Neurosci Lett. 2008 Dec 3;446(2-3):108-11. doi: 10.1016/j.neulet.2008.09.058.

PMID:
18835330
12.

Gene for the serotonin transporter and ADHD: no association with two functional polymorphisms.

Wigg KG, Takhar A, Ickowicz A, Tannock R, Kennedy JL, Pathare T, Malone M, Schachar R, Barr CL.

Am J Med Genet B Neuropsychiatr Genet. 2006 Sep 5;141B(6):566-70.

PMID:
16856124
13.

Possible effect of norepinephrine transporter polymorphisms on methylphenidate-induced changes in neuropsychological function in attention-deficit hyperactivity disorder.

Park S, Kim JW, Yang YH, Hong SB, Park MH, Kim BN, Shin MS, Yoo HJ, Cho SC.

Behav Brain Funct. 2012 May 16;8:22. doi: 10.1186/1744-9081-8-22.

14.

Response to methylphenidate in adults with ADHD is associated with a polymorphism in SLC6A3 (DAT1).

Kooij JS, Boonstra AM, Vermeulen SH, Heister AG, Burger H, Buitelaar JK, Franke B.

Am J Med Genet B Neuropsychiatr Genet. 2008 Mar 5;147B(2):201-8.

PMID:
17955457
15.

Novel and functional norepinephrine transporter protein variants identified in attention-deficit hyperactivity disorder.

Hahn MK, Steele A, Couch RS, Stein MA, Krueger JJ.

Neuropharmacology. 2009 Dec;57(7-8):694-701. doi: 10.1016/j.neuropharm.2009.08.002. Epub 2009 Aug 19.

16.

No association between two polymorphisms of the serotonin transporter gene and combined type attention deficit hyperactivity disorder.

Xu X, Duman EA, Anney R, Brookes K, Franke B, Zhou K, Buschgens C, Chen W, Christiansen H, Eisenberg J, Gabriëls I, Manor I, Marco R, Müller UC, Mulligan A, Rommelse N, Thompson M, Uebel H, Banaschewski T, Buitelaar J, Ebstein R, Gill M, Miranda A, Mulas F, Oades RD, Roeyers H, Rothenberger A, Sergeant J, Sonuga-Barke E, Steinhausen HC, Taylor E, Faraone SV, Asherson P.

Am J Med Genet B Neuropsychiatr Genet. 2008 Oct 5;147B(7):1306-9. doi: 10.1002/ajmg.b.30737. Erratum in: Am J Med Genet B Neuropsychiatr Genet. 2009 Mar 5;150B(2):307. Duman, Elif Aysimi [corrected to Duman, EA]. Am J Med Genet B Neuropsychiatr Genet. 2009 Jan 5;150B(1):154.. Aysimi, E [corrected to Duman, Elif Aysimi].

PMID:
18452186
17.

Human genetics and pharmacology of neurotransmitter transporters.

Lin Z, Madras BK.

Handb Exp Pharmacol. 2006;(175):327-71. Review.

PMID:
16722243
18.

No evidence of linkage or association between the norepinephrine transporter (NET) gene MnlI polymorphism and adult ADHD.

De Luca V, Muglia P, Jain U, Kennedy JL.

Am J Med Genet B Neuropsychiatr Genet. 2004 Jan 1;124B(1):38-40.

PMID:
14681910
19.

No evidence of linkage or association between the norepinephrine transporter (NET) gene polymorphisms and ADHD in the Irish population.

McEvoy B, Hawi Z, Fitzgerald M, Gill M.

Am J Med Genet. 2002 Aug 8;114(6):665-6. No abstract available.

PMID:
12210284
20.

Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder.

Biederman J, Spencer T.

Biol Psychiatry. 1999 Nov 1;46(9):1234-42. Review.

PMID:
10560028

Supplemental Content

Support Center